Literature DB >> 11084416

[Contribution of immunohistochemistry and electron microscopy for the diagnosis of meningeal hemangiopericytomas. 15 case reports].

C Bouvier-Labit1, A Liprandi, M D Piercecchi, H Hosseini, D Hénin, D Figarella-Branger.   

Abstract

Meningeal hemangiopericytomas (HPC) are rare CNS tumors with a pour prognosis compared to meningiomas. In order to define diagnosis criteria, we performed an immunohistochemical and ultrastructural study in respectively 15 and 5 meningeal HPC. The following antibodies anti-KL1, EMA, vimentin, CD34, factor VIII, alpha-smooth actin, estrogen and progesteron receptors (RE, RP) were used in paraffin embedded sections whereas anti-NCAM and E-cadherin antibodies were used on frozen sections when available. We can differentiate meningeal HPC from meningioma because of a complete lack of immunostaining with epithelial markers as well as with NCAM antibody or RE and RP receptors. Besides a positivity with CD34 and alpha-smooth actin antibodies was always observed even focally in HPC. On the other hand, solitary fibrous tumor showed a strong and diffuse positivity with anti CD34 and anti-vimentin antibodies. Electron microscopy can be helpful in some instances showing membrane basal-like substance and absence of desmosomes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11084416

Source DB:  PubMed          Journal:  Ann Pathol        ISSN: 0242-6498            Impact factor:   0.407


  3 in total

1.  High throughput screening of meningioma biomarkers using a tissue microarray.

Authors:  Eriks A Lusis; Michael R Chicoine; Arie Perry
Journal:  J Neurooncol       Date:  2005-07       Impact factor: 4.130

2.  Meningeal hemangiopericytoma only diagnosed at the time of late bone metastasis.

Authors:  Kantang Satayasoontorn; Alberto Righi; Marco Gambarotti; Biagio Merlino; Eugenio Brunocilla; Daniel Vanel
Journal:  Skeletal Radiol       Date:  2014-06-17       Impact factor: 2.199

3.  [The meningeal hemangiopericytoma: a rare intracranial tumor - about a case].

Authors:  Amal Errachdi; Amal Asabbane; Brice Nkoua Epala; Mariem Hemmich; Naoual Kabbali; Adama Diakité; Tayeb Kebdani; Noureddine Benjaafar
Journal:  Pan Afr Med J       Date:  2014-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.